(Q44705841)

5 December 2017

Cognitive impairment associated with atorvastatin and simvastatin (English)

1 reference

5 December 2017

cognitive dysfunction

1 reference

Deborah S King

1

1 reference

5 December 2017

Amanda J Wilburn

2

1 reference

5 December 2017

Marion R Wofford

3

1 reference

5 December 2017

T Kristopher Harrell

4

1 reference

5 December 2017

Brent J Lindley

5

1 reference

5 December 2017

Daniel W Jones

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Pharmacotherapy

1 reference

5 December 2017

23

1 reference

5 December 2017

1663-1667

1 reference

5 December 2017

12

1 reference

Simvastatin-associated memory loss

5 December 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Statins and blood pressure regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Stimulation of bone formation in vitro and in rodents by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Use of statins and the subsequent development of deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Effects of lovastatin on cognitive function and psychological well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.15.1663.31953

10.1592/PHCO.23.15.1663.31953

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference